Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,348 | -32,996 | -16,360 | 10,733 | 17,952 |
| Depreciation Amortization | 832 | 544 | 256 | 2,078 | 1,860 |
| Income taxes - deferred | N/A | N/A | N/A | 1,811 | N/A |
| Accounts receivable | 2,245 | 2,148 | 2,767 | -1,322 | -403 |
| Other Working Capital | -74 | 2,175 | 822 | 6,532 | 4,378 |
| Other Operating Activity | 4,361 | 2,760 | -231 | -314 | 3,470 |
| Operating Cash Flow | $-40,984 | $-25,369 | $-12,746 | $19,518 | $27,257 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -226 | -203 | -113 | -3,939 | -2,920 |
| Investing Cash Flow | $-226 | $-203 | $-113 | $-3,939 | $-2,920 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 48,650 | N/A |
| Common Stock Issued | 470 | 411 | 232 | 1,340 | 510 |
| Other Financing Activity | 21 | 153 | 0 | -368 | 0 |
| Financing Cash Flow | $491 | $564 | $232 | $49,622 | $510 |
| Exchange Rate Effect | 93 | 60 | 25 | -86 | -56 |
| Beginning Cash Position | 140,910 | 140,910 | 140,910 | 75,795 | 74,103 |
| End Cash Position | 100,284 | 115,962 | 128,308 | 140,910 | 98,894 |
| Net Cash Flow | $-40,626 | $-24,948 | $-12,602 | $65,115 | $24,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,984 | -25,369 | -12,746 | 19,518 | 27,257 |
| Capital Expenditure | -263 | -240 | -145 | -4,286 | -3,261 |
| Free Cash Flow | -41,247 | -25,609 | -12,891 | 15,232 | 23,996 |